RM Infrastructure Income has been in a managed wind-down process since 20 December 2023. On 25 September 2024, a successful tender offer returned c.£17.5m to shareholders at 88.59 pence per share (the NAV on 30 August 2024). This represented 16.6% of the issued share capital. Today, the trust is launching a tender offer of up […]
Odyssean Investment Trust’s results for the year ended 31 March 2025 show a 10.7% fall in NAV and 13.5% fall in share price, and a shift from trading on a small premium to a small discount (2.5%). The returns fall short of the return on the Deutsche Numis Smaller Companies ex Investment Companies plus AIM […]
HarbourVest Gobal Private Equity says that, for the year ended 31 January 2025, it generated a NAV return (in dollars) of 7.3% and a share price return (in sterling) of 19.2% (as the discount narrowed from 42% to 35%). The trust announced a range of measures on 30 January 2025 that are aimed at narrowing […]
Shires Income has announced results covering the 12 month period that ended on 31 March 2025. The trust returned 9.5% in NAV terms and 22.4% in share price terms (as the discount narrowed from 13.3% to 3.7%). By contrast the return on the All-Share index benchmark was 10.5%. The full-year dividend of 14.8p matches Shires’ […]
JPMorgan Japanese has announced that Xuming Tao has been made a co-manager of the trust, working alongside the existing team of Nicholas Weindling and Miyako Urabe. Xuming has been a member of the Japanese equity team at JPMAM in Tokyo since 2019 and was a co-manager of JPMorgan Japan Small Cap Growth & Income before […]
In QuotedData’s morning briefing 29 May 2025: We also have: Did you see yesterday?
In QuotedData’s morning briefing 27 May 2025: Did you see from Friday?
HarbourVest Private Equity says it will change the way it invests – moving from investing through HarbourVest Partners’ co-mingled funds to direct investments in third party funds, secondary opportunities and co-investments – a ‘separately managed account’. The transition to the new structure will be gradual as new commitments are invested this way, while the existing […]
BioPharma Credit highlights yesterday’s announcement that Paratek has completed its purchase of OPTN. In connection with this, BioPharma Credit received $82.8m, $71.5m was the repayment of the loan it had made to OPTN and $11.3m came as ‘make-whole’ and prepayment fees, and accrued interest. There is another $1.6m to come in connection with the company’s […]
STS Global Income & Growth has published results covering the 12 month period ended 31 March 2025, and they are good. The NAV and share price return were both 10.9% over the period which compares to a return on the Lipper Global – Equity Global Income Index of 4.5%. The total dividend for the year […]
